Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Sterigenics U.S. LLC
EIR
•Sterigenics U.S. LLC•April 27, 2018

Sterigenics U.S. LLC – FDA EIR, Apr 27, 2018

Record Details

An FDA inspection of Sterigenics U.S. LLC in Mulberry, FL, conducted from April 24-27, 2018, identified significant deficiencies in their contract gamma sterilization processes for medical devices. The inspection was carried out under Compliance Programs for Human Cells, Tissues, and Cellular and Tissue Based Products (HCT/Ps) and Medical Device Manufacturers, referencing the Federal FD&C Act and Public Health Service Act. The main violations, documented on an FDA Form 483, concerned process validation (21 CFR 820.75(a)) and acceptance activities (21 CFR 820.80(a)). Firstly, the company processed medical devices whose weights deviated significantly (up to 30%) from validated load specifications. This raised concerns that the gamma irradiation process might not consistently achieve the intended sterilization dose, especially since their own studies indicated dose distribution is affected by product density variations within a load. The company's method of placing dosimeters was questioned for its accuracy in these varied conditions. Secondly, Sterigenics lacked adequate written procedures for verifying incoming medical device packages met required specifications, such as dimensions, weight, and density, before sterilization. Although personnel performed these checks informally, the absence of documented procedures and records meant critical quality assurance steps were not formally controlled or verified. In response, Sterigenics committed to conducting additional qualification studies to address product density variations and to ensure customers comply with package specifications or require new dose mapping. They also promised to establish formal written procedures for acceptance activities and record keeping.

Company
Sterigenics U.S. LLC
Inspection date
April 27, 2018
Product type
devices
Office
Office of Biological Products Operations - Division II
People
  • Phillip MacNabb (company_representative)
  • Susan Olsen (company_representative)
  • Holley F. Staskiewicz (company_representative)
  • Brenda L. Kuska (company_representative)
  • Joshua J. Silvestri
View Company Profile

ID · 1a8b4bc7-deef-4575-b6fc-22f0093b1bae

Violation Codes4
21 CFR 820.19821 CFR 82021 CFR 820.80(a)21 CFR 820.75(a)

Full citation text and observation details available on the Dashboard.

Other documents for Sterigenics U.S. LLC
  • 483 - 2024-07-11July 11, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sterigenics U.S. LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.